The University of Chicago Header Logo

Connection

Barbara Hendrickson to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Barbara Hendrickson has written about Janus Kinase Inhibitors.
Barbara Hendrickson
Connection Strength
0.169
Janus Kinase Inhibitors
  1. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021 06 05; 397(10290):2169-2181.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.